![SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00997-x/MediaObjects/41392_2022_997_Fig1_HTML.png)
SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy
![More than 50 long-term effects of COVID-19: a systematic review and meta-analysis | Scientific Reports More than 50 long-term effects of COVID-19: a systematic review and meta-analysis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-95565-8/MediaObjects/41598_2021_95565_Fig2_HTML.png)
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis | Scientific Reports
![Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study | Nature Communications Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-024-46692-z/MediaObjects/41467_2024_46692_Fig1_HTML.png)
Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study | Nature Communications
![Lung Fibrosis: Hypertension, Lung Fibrosis & Asthma Long-term Effects Of Covid, Reveals Study | Pune News - Times of India Lung Fibrosis: Hypertension, Lung Fibrosis & Asthma Long-term Effects Of Covid, Reveals Study | Pune News - Times of India](https://static.toiimg.com/thumb/imgsize-23456,msid-103682766,width-600,resizemode-4/103682766.jpg)
Lung Fibrosis: Hypertension, Lung Fibrosis & Asthma Long-term Effects Of Covid, Reveals Study | Pune News - Times of India
![Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/4d3ad98c-ff69-47b5-bd38-ee4e91a8be30/gr2.jpg)
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity
![25% of COVID-19 patients still have symptoms after 18 months | The Asahi Shimbun: Breaking News, Japan News and Analysis 25% of COVID-19 patients still have symptoms after 18 months | The Asahi Shimbun: Breaking News, Japan News and Analysis](https://p.potaufeu.asahi.com/cf56-p/picture/26873470/10ef40dbd67c65d537a69d0eec4e55ab.jpg)
25% of COVID-19 patients still have symptoms after 18 months | The Asahi Shimbun: Breaking News, Japan News and Analysis
![COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/Long-Covid-Brain-opening-image-1.jpg)
COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis
![COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/Long-Covid-Brain1.jpg)